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Abstract: Efficient intracellular drug delivery and target specificity are often hampered by the
presence of biological barriers. Thus, compounds that efficiently cross cell membranes are the key to
improving the therapeutic value and on-target specificity of non-permeable drugs. The discovery of
cell-penetrating peptides (CPPs) and the early design approaches through mimicking the natural
penetration domains used by viruses have led to greater efficiency of intracellular delivery. Following
these nature-inspired examples, a number of rationally designed CPPs has been developed. In this
review, a variety of CPP designs will be described, including linear and flexible, positively charged
and often amphipathic CPPs, and more rigid versions comprising cyclic, stapled, or dimeric
and/or multivalent, self-assembled peptides or peptido-mimetics. The application of distinct design
strategies to known physico-chemical properties of CPPs offers the opportunity to improve their
penetration efficiency and/or internalization kinetics. This led to increased design complexity of new
CPPs that does not always result in greater CPP activity. Therefore, the transition of CPPs to a clinical
setting remains a challenge also due to the concomitant involvement of various internalization routes
and heterogeneity of cells used in the in vitro studies.
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1. Introduction
Cell-penetrating peptides (CPPs) are short peptides (<30 amino acids long) that are able to
penetrate biological membranes and drive the internalization of a bioactive cargo in cells. An alternative
terminology, the protein transduction domain (PTD), was used initially to describe such peptides
as the first examples of CPPs were based on natural peptides derived from protein fragments [1].
Discovered in the 1990s, the first reported examples of CPPs were the Tat peptide (positions 48–60,
derived from the transcription protein of HIV-1) [2,3] and penetratin (derived from the amphiphilic
Drosophila Antennapedia homeodomain) [4]. Inspired by these molecules and focused mainly on
positively charged sequences, many CPPs with differences in charge, polarity and/or structure have
been discovered and/or designed [5,6]. Positively and negatively charged, amphipathic (primary or
secondary) and non-amphipathic CPPs are used today in in vitro and in vivo studies [1,7–10].
A CPP database, established in 2012 and now updated to CPP version 2.0, is a useful source
of information [11,12]. Interestingly, the statistics section of the CPP database site (Figure 1) reveals
that there are 1699 unique CPP sequences and that most are linear CPPs (94.5%) (Figure 1a) used for
the delivery of fluorophores (58.4%) (Figure 1b). The major cargo of biomedical relevance is nucleic
acids (16%). In addition, proteins (9%), nanoparticles (7.8%) and peptide therapeutics (4.7%) are other
cargoes of interest (Figure 1b). The main body of research on CPPs focuses on synthetic peptides
(54.8%) based on L-amino acids (84.3%) (Figure 1c). Moreover, the internalization efficiency and
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stability of all D-stereoisomers have been reported alongside CPP sequences composed of L- and D-
combinations (Figure 1c) [11,12].
Extensive literature is available on the structure–activity relationship of primary CPPs and the
folding properties of amphipathic peptides [1,7,12,13]. Charge and amphipathicity are the two main
structural parameters taken into consideration when designing CPPs. Moreover, internalization
can vary in function of overall amphipathicity and polycationic nature. In addition, the role of
properties such as sequence length and conformation in internalization is equally as important as the
accumulation of positive charge [7].
The folding ability of CPPs to form α-helices and β-sheets increases their efficiency to penetrate
cells, as described in more detail in Section 4.2 [10,14,15]. However, the challenge is to introduce
this property in a controlled and programmable manner through rational design. This review will
address new concepts and strategies through which the rational design of CPPs can serve to enhance
the efficiency of internalization and regulate the kinetics of this process.
Molecules 2017, 22, 1929 2 of 36 
 
(54.8%) based on L-amino acids (84.3%) (Figure 1c). Moreover, the internalization efficiency and 
stability of all -stereoiso ers have been reported alongside PP sequences co posed of L- and - 
co binations (Figure 1c) [11,12]. 
Extensive literature is available on the structure–activity relationship of pri ary PPs and the 
folding properties of a phipathic peptides [1,7,12,13]. harge and a phipathicity are the t o ain 
structural para eters taken into consideration when designing CPPs. Moreover, internalization can 
vary in function of overall amphipathicity and polycationic nature. In addition, the role of properties 
such as sequence length and conformation in internalization is equally as important as the 
accu ulation of positive charge [7].  
The folding ability of PPs to for  α-helices and β-sheets increases their efficiency to penetrate 
cells, as described in more detail in Section 4.2 [10,14,15]. However, the challenge is to introduce this 
property in a controlled and programmable manner through rational design. This review will address 
new concepts and strategies through which the rational design of CPPs can serve to enhance the 
efficiency of internalization and regulate the kinetics of this process. 
 
Figure 1. Statistical graphic representations depicting the distribution of cell-penetrating peptides 
(CPPs) reported in the literature (based on 1855 entries, of which 1699 are unique peptides) on the 
basis of the following: (a) linear and cyclic structure; (b) type of cargo delivered; and (c) chirality 
(taken from the CPP 2.0 database), taken from reference [12]. 
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Many key parameters, such as origin [16], translocation mechanisms [7], physico-chemical 
properties [9] and others [17], have been proposed for the classification of CPPs. According to 
Eiríksdóttir et al., CPPs can be placed into the following three main groups: PTDs (Tat, Penetratin, 
etc.); model peptides (R9, KLAK); and designed peptides (Pep-1, sequence: KETWWETWWTEWS 
QPKKKRKV) [15]. Inspired by Tat (GRKKRRQRRRPQ) and penetratin (RQIKIWFQNRRMKWKK), 
the design of model CPPs is often based on small, cationic peptides (with charge ~5+) with low 
sequence diversity, such as polyarginines and polylysines. The most widely studied oligoarginine-
based CPPs are R8 and R9 [18]. The uptake efficiency of polycationic CPPs was shown to depend on 
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2. From Protein Domains to the Design of Peptides with Cell Penetration Properties
2.1. Natural and Fusion Sequences
Many key parameters, such as origin [16], translocation mechanisms [7], physico-chemical
properties [9] and others [17], have been proposed for the classification of CPPs. According to
Eiríksdóttir et al., CPPs can be placed into the following three main groups: PTDs (Tat,
Penetratin, etc.); model peptides (R9, KLAK); and designed peptides (Pep-1, sequence:
KETWWETWWTEWSQPKKKRKV) [15]. Inspired by Tat (GRKKRRQRRRPQ) and penetratin
(RQIKIWFQNRRMKWKK), the design of model CPPs is often based on small, cationic peptides
(with charge ~5+) with low sequence diversity, such as polyarginines and polylysines. The most
widely studied oligoarginine-based CPPs are R8 and R9 [18]. The uptake efficiency of polycationic
CPPs was shown to depend on sequence length and also on the position of the arginine residue in the
peptide sequence [19,20]. Recently, cyclization has been reported to maximize arginine contacts with
the membrane, thereby achieving higher uptake efficiencies [21].
The first designed CPPs sought to increase the efficiency of individual known CPPs by including
fusion sequences containing specific functions of interest [15]. An example is Pep-1, which includes the
following: a hydrophobic tryptophan-rich segment (five tryptophan residues) to favor hydrophobic
interactions with membranes; a positively charged lysine-rich segment (KKKRKV), used as a nuclear
localization sequence derived from a virus (SV-40 T-antigen); and a proline spacer to increase the
flexibility of the sequence [22]. Similarly, MPG (GALFLGFLGAAGSTMGAWSQPKKKRKV) was
designed to contain the same hydrophilic nuclear localization sequence added to a viral hydrophobic
domain derived from the HIV-gp-41 segment [23]. The integration of cationic, hydrophobic and
amphipathic segments in different combinations led to the discovery of more efficient CPPs [5].
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Furthermore, Giralt and co-workers reported on the discovery of a different class of CPPs,
namely proline-rich amphipathic peptides, such as SAP (sweet arrow peptide) and its derivatives [24].
The SAP sequence (VRLPPP)3 was derived from the N-terminus of γ-zein VHL(PPP)8, a storage
protein of maize. This peptide was found to adopt a polyproline II helical structure and it has the
ability to self-aggregate.
CPP design has improved in order to address various challenges such as internalization
efficiency, endosomal escape efficiency, circulation times, and specificity and selectivity (for cells,
tissues, diseases). An example to mention are cysteine rich peptides [25]. A novel CPP was
derived from a toxin found in snake venom, crotamine, that contains two nuclear localization
domains (crot(2–18) and crot(27–39)). A cysteine-rich decapeptide (CRWRWKCCKK) with enhanced
internalization properties was identified through examination of various versions of crot(27–39)
(sequence: KMDCRWRWKCCKK) by systematic substitution and/or deletion of amino acid residues,
coupled to structure–activity relationship studies [25].
A recent example of hydrophobic viral peptide having cell penetrating properties is gH 625
(sequence: HGLASTLTRWAHYNALIRAF) [26,27]. This CPP, derived from Herpes Simplex virus
type I, was used to improve the delivery of liposomes [28,29], quantum dots [30], dendrimers [31],
intrinsically disordered proteins [32] and SPIONS [33].
2.2. Structural and Functional Plasticity
CPPs have interfacial activity [7]. For most, membrane binding requires electrostatic interactions
and/or peptide amphipathicity. In the literature, two main families of CPPs, namely arginine-rich and
proline-rich, have been widely described, as have their mechanisms of internalization [19,20,24,34].
Futaki and others examined the behavior of oligoarginines on the basis of their sequence length and
position of arginine in the sequence [19,20]. Interestingly, the study of oligoarginines (Rn) with n = 4–16
residues has shown that the optimal number of arginine residues for efficient translocation is n = 8 [20].
Giralt and co-workers reported on the polyproline CPPs that tend to assume the helical conformations
responsible for their internalization [24].
Many other CPPs are amphipathic and are able to fold into α-helical and β-sheet-like structures [9].
These molecules are referred to as primary or secondary amphipathic CPPs, on the basis of their
amphipathic primary sequence or the ability to assume amphipathicity when folded, respectively [9].
Some of them fold only in the presence of membranes while others tend to assume secondary structures
in solution, before interaction with membranes [9]. In addition, these CPPs can undergo conformational
changes upon contact with membranes [35].
This ability to assume a higher order of organization through folding (intramolecular weak
interactions) can also be achieved via controlled self-assembly through intermolecular, non-covalent
interactions between CPP monomeric units [36]. While folding is widely explored in the CPP field,
little attention has been paid to the propensity of CPPs to self-assemble in a controlled fashion. Short
peptide amphiphiles fold in a similar manner to that of proteins and their amino acid sequence confers
self-assembly propensity [37]. Of note, α-helical and β-sheet-like assemblies are the most widely
studied systems.
The examples of CPPs mentioned above reflect the enormous functional sequence space of these
molecules. Sequence length and conformation are key parameters that drive internalization [15].
However, peptide sequence and structure (i.e., the primary and secondary organizational level,
respectively) alone are not enough to define and/or predict the mechanism of action as internalization
is also determined by factors such as peptide concentration, membrane lipid composition, cargo,
charge, self-assembly state, folding properties of CPPs and their amphipathic character, response of
the cell to the peptide, temperature, and ionic strength, among others [7].
Some important challenges regarding CPPs remain to be addressed, namely internalization/
translocation efficiency, often through improved endosomal escape, lack of target specificity, stability to
proteases, and cytotoxicity [38]. Although the first reports on CPPs were based on protein derivatives,
Molecules 2017, 22, 1929 4 of 38
rational design is now dominating research activity in the field. Synthetic tools have paved the way
to explore new approaches to improve the cell penetration of CPPs and CPP-therapeutic conjugates,
both covalent and non-covalent. In addition to combining various known peptide sequences and
introducing specific amino acid residues (Arg, Lys, Trp, Cys) into CPP design to improve efficiency,
hydrocarbon chains were included in these peptides in order to increase their circulation times [39].
Moreover, disease-specific targeting moieties such as RGD or homing peptide sequences were added to
achieve cell and tissue targeting (e.g., cancer cells) [40,41]. A new direction comprises the development
of activatable CPPs where a pH- or an enzyme-responsive moiety are added to the design [40,42,43].
This approach makes the peptides stimuli-responsive to the tumor microenvironment, a property
that can result in increased selectivity [44,45]. In addition, cyclization and stapling were proposed
to achieve increased metabolic stability but also higher internalization efficiency as a result of
increased structural or conformational rigidity/stability. Alternatively, multivalency of covalent
dimers (primary), stabilized helices (secondary/tertiary) and supramolecular structures (quaternary)
can be used to improve internalization. In this review, we wish to highlight how chemistry and rational
design contribute to the CPP field.
3. Mechanistic Challenges
3.1. Internalization Mechanisms
CPPs, with or without cargo, can enter cells actively (energy-dependent mechanism) or passively
(energy-independent mechanism) [7]. The physical chemistry of peptide–membrane interactions
is crucial for efficient cell penetration. Many factors, including high positive charge content,
cell membrane composition, endosomal escape, cargo, amphipathicity and folding ability, influence the
mechanism and efficiency of cell penetration [7], thus making internalization a complex process.
Initially, it was thought that CPPs entered cells through energy-independent mechanisms and
mainly through direct translocation [46]. Later, it was found that these initial studies were biased by
cell fixation artifacts and that various mechanisms might be involved simultaneously in cell entry of
CPPs [46]. Since then, progress has been made in understanding the uptake mechanisms of CPPs, and it
has been shown that endocytic mechanisms, and in particular micropinocytosis, are involved [19].
However, other endocytic pathways, namely clathrin- and caveolin-mediated endocytosis, also trigger
the internalization of CPPs [24]. Futaki and co-workers found that macropinocytosis plays a crucial role
in the cellular uptake of arginine-rich peptides [19]. However, these peptides can also be internalized
by direct translocation through the plasma membrane [19]. Proline-rich CPPs, characterized by the
presence of pyrrolidine rings, enter cells via caveolae- or lipid-raft-mediated endocytosis [24].
A comprehensive overview of the mechanisms of uptake of several CPPs on the basis of their
physico-chemical properties has been given elsewhere [7]. Interestingly, Wimley and co-workers
classified CPPs on the basis of their mechanism of internalization. According to those authors,
CPPs can translocate by the following: (a) plasma membrane lysis; (b) spontaneous (passive) membrane
translocation; (c) energy-dependent membrane translocation; (d) transient membrane disruption;
and (e) energy-dependent membrane disruption. Membrane lysis is not a desired parameter when
designing CPPs as it might result in cytotoxicity at low peptide concentrations [7]. A hallmark of CPPs
is translocation without lysis or membrane disruption.
A better understanding of the CPP-internalization mechanisms allows improved rational design
of selective and efficient CPPs. The main challenge continues to be an incomplete understanding of
the precise mechanism of cell entry. It is well documented that several mechanisms are concomitantly
involved in this process, and there is still active debate in the field about this topic. Importantly,
for the variety of CPPs described to date, it is not possible to predict their behavior or internalization
mechanism based on structural information alone. In the future, it would be advantageous to use
specific design parameters to guide the desired internalization routes in a programmed manner.
Progress has recently been made in this regard [21,47–50].
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3.2. Membrane Composition
In addition to the sequence and structure of the peptides, another parameter that influences
membrane interaction with CPPs and therefore CPP internalization efficiency is membrane
composition [1,51]. Proteoglycans (heparin sulfate proteoglycans and syndecans)—components of
the extracellular matrix and regulators of cell surface microdomains—are essential for interaction
with CPPs through electrostatic binding. This electrostatic interaction facilitates the accumulation of
CPPs at the cell surface and constitutes the first contact with the cell membrane. This first interaction
activates a variety of internalization mechanisms that lead to CPP internalization. One of the major
differences between CPPs is their ability to interact with the membrane/cellular surface components.
For example, cationic peptides bind through electrostatic interactions and hydrogen bonding through
the guanidinium group, therefore various endocytic pathways can act simultaneously [52–54].
Amphipathic peptides interact with lipids and often tend to adopt secondary structure in the presence
of membranes. A high local concentration of CPPs at the membrane surface can lead to the formation
of transient secondary structures (lipid-hydrophobic domain of CPP interaction). As most cancer cell
surfaces have an overall negative charge, the cellular uptake efficiency of positively charged molecules
outperforms that of negatively charged ones [55].
Recently, it has been shown that receptor-mediated internalization is important in the uptake of
R8. Futaki and coworkers identified syndecan-4 as the proteoglycan that acts as the cell surface target
responsible for the uptake of R8 via clathrin-mediated endocytosis [34]. In their approach based on
photo crosslinking, 17 membrane-associated proteins were found to interact with R8 and potentially
mediate its internalization. By using knockdown experiments in combination with pharmacological
inhibitors, those authors found that syndecan-4 was the membrane-associated receptor preferentially
associated with R8 uptake. The same group showed how a chemokine receptor (CXCR4) was involved
in the macropinocytic internalization of the oligoarginine R12 peptide [56]. In summary, the interplay
of various mechanisms is involved in the internalization of CPPs, and therefore a number of structural
parameters drive this translocation process.
3.3. Endosomal Escape
Endocytosis is one of the main routes for CPP internalization. It is an energy-dependent
process that involves several pathways, classified as the following: (a) micropinocytosis; (b) clathrin-
or caveolin-mediated endocytosis; and (c) clathrin- or caveolin-independent endocytosis [8,57].
Endocytosis consists of the uptake of extracellular material through encapsulation into vesicular
compartments, called endosomes (Figure 2a). During endocytic internalization, endosomal release
(escape) is the rate-limiting step for the efficiency of CPPs to reach intracellular targets [8,58]. A number
of strategies to improve endosomal escape have been reported [51,54,59–61]. The main examples
include the use of acid–labile bonds, endosome-disrupting peptides or polymers, and rupture of
endosomal membranes with lasers [51,61].
Inspired by the ability of viruses to destabilize the endosomal lipid bilayers by insertion of motifs
containing hydrophobic amino acid side chains, researchers addressed the covalent attachment of
hydrophobic so-called ‘endosomal escape domains’ [59,62]. Dowdy and co-workers reported on the
design of these domains by exploring combinations of hydrophobic amino acids based on tryptophan
and phenylalanine (Figure 2b) [59]. Futaki and co-workers described penetration-accelerating
sequences (Pas) [63,64]. Enhanced translocation was obtained by attaching the hydrophobic FFLIPKG
sequence to the cationic CPP R8. Additionally, stearylation was reported to promote endosomal escape
when compared to the unmodified peptide [65].
pH-sensitive materials are often designed to have modular behavior depending on the
environment [66,67]. CPPs can switch their properties and become membrane lytic when
in contact with the lower pH values found in endosomes [55]. An example is the GALA
peptide (sequence: WEAALAEALAEALAEHLAEALAEALEALAA), which contains glutamic acid
residues [67]. This peptide has an overall negative charge in the extracellular region, which prevents
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lytic activity. Once in the endosomes and exposed to a slightly acidic pH, these glutamic acid residues
are protonated, the charge is reduced, and a helical structure able to lyse the endosomal membranes is
formed [55,68].
Recently, the use of endosmolytic peptides, inspired by the spider venom M-lycotoxin,
was proposed for intracellular delivery of antibodies [69]. Analogs of the spider venom peptide
were designed by introducing one or two glutamic acid residues into the hydrophobic part of the
amphipathic helix. In this regard, the membrane lytic activity of the natural cationic venoms decreased,
while selective perturbation of endosomes was achieved [69].
Cysteine oxidation state seems to be important for improving efficiency through endosomal
escape [25,70]. Cysteines are able to form disulfide bridges in oxidative conditions, resulting in
cyclization when they are intramolecular, or giving rise to oligomers or aggregates when they are
intermolecular. A study of selective controlled oligomerization that leads to dimer formation and
results in enhanced uptake, followed by the reduction to monomers in the cytosol, was reported.
However, this behavior was found to be dependent on the cell type used [25].
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3.4. Influence of Cargo
An important application of CPPs is their use in drug delivery and as diagnostic tools, both in vitro
and in vivo [38,71,72]. Recently, CPP-derived therapeutics have reached preclinical evaluations
and some have even entered clinical trials [8]. CPPs are able to aid the delivery of therapeutic
molecules and/or imaging agents to cells and tissues. The cargo can be introduced through
covalent modifications or non-covalently by exploiting weak interactions between CPPs and cargo
molecules [73]. Covalent conjugation of CPPs to peptidic drugs, proteins (e.g., antibodies, insulin,
etc.), small chemotherapeutic drugs (e.g., oxorubicin, methotrexate, paclitaxel, etc.) and nucleic acids
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has been reported [38,71]. Non-covalent cargo loading is achieved mainly through the formation of
complexes with oligonucleotides [38,71,74–76]. The type of cargo, its influence on the internalization
mechanisms and/or efficiency of CPPs have been extensively reviewed elsewhere [38,71,72,77].
4. Design Strategies
In the language of protein folding, primary structure refers to the amino acid sequence that
encodes all the information necessary for folding and assembly into higher organizational levels
(secondary, tertiary and quaternary structures). Based on the same principles, short peptides are
able to adopt secondary structure segments such as α-helices and β-sheets. These conformational
propensities are driven by weak non-covalent interactions such as electrostatic interactions, hydrogen
bonding, hydrophobic effect or Van der Waals forces. In addition, short peptide amphiphiles are
prone to self-assembly due to intermolecular weak interactions between peptide monomers [37,78].
Today, chemistry offers numerous design opportunities that can be introduced in a programmed
and controlled manner. Here, we will describe the CPP design strategies in four sub-sections with
increasing structural complexity, based on the classic language of protein folding.
4.1. The Importance of the Primary Sequence
The following generic parameters are necessary for CPPs to cross membranes: guanidinium
content, hydrophobicity and amphipathicity [79]. The primary structure–function relationship has
been extensively studied for arginine-rich CPPs, as described above [19]. Membrane models, as well
as membrane extracts, followed by in vivo studies, have often been used to determine sequence
and single residue (e.g., positive charge) contributions. However, it is difficult to predict whether
a certain peptide will have the potential to cross the membrane on the basis of peptide sequence.
Several chemical and physico-chemical properties such as charge, chirality, aromatic and hydrophobic
content and often their interplay are important drivers of CPP internalization [15,80].
Although effort has been made to understand the contributions of single parameters to
CPP passage through membranes, the combinations of charge, guanidinium, hydrophobicity and
aromaticity are often explored to obtain more efficient CPPs [81]. Recently, synthetic mimics of
CPPs (CPPMs) were developed to control the contribution of charge, hydrophobic functionality,
π-electronics and helicity [81]. Ring-opening metathesis polymerization was used to synthesize these
mimetics, yielding polypeptides carrying various functionalities of interest. These synthetic polymers
are valuable tools for studying CPP–membrane interactions and for elucidating the contribution of
individual parameters of the translocation process. The advantage of such polymers is that the desired
variability can be introduced in the primary structure in a programmed manner.
Cationic and arginine-rich CPPs. Peptide sequences rich in cationic amino acid side chains hold
great promise in the CPP field [19,20,64,82,83]. Following the discovery of Tat, which contains nine
arginine and two lysine residues, it is not surprising that the simplest CPP mimics were oligoarginines.
In the early 2000s, the correlation between high levels of cell uptake and inclusion of cationic residues
in the CPP design was confirmed [84]. Since then, interest has focused on studying polycationic
compounds with a variety of scaffolds containing repeating arginine residues, which promote cell
penetration. Positive charge can also be introduced through other amino acid side chains, such as lysine
and histidine. However, polyarginines outperformed polylysines and polyhistidines [17,85]. Therefore,
polyarginines are also the most studied CPPs in terms of mechanism of internalization and introduction
of designs. Subsequently, it has been noted that the efficiency with which linear polyarginines are taken
up differs depending on sequence length and also on the number and position of arginine residues in
the sequence [19,34]. The guanidinium group has the capacity to form bidentate hydrogen bonds with
membranes and it is therefore relevant for membrane translocation (Figure 3a) [86,87].
In addition, non-natural amino acids (D-stereoisomers) and/or synthetic mimics containing
guanidinium moieties or other positively charged chemical entities have been explored [21].
Synthetic mimics are advantageous as various chemical entities can be introduced in a controlled
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manner. Other advantages include their resistance to proteases and the possibility to study specific
contributions of single sequence components. An example is a comparative study in which the authors
evaluated a lysine-rich CPP, namely Pep-1, against the guanidinium-bearing CPP mimic [88]. For this
purpose, a guanidinium-rich 9-mer was synthesized by ring opening metathesis polymerization,
with two guanidines per repeat unit, designed to mimic Tat (Figure 4d). The results revealed that the
mimic showed better performance than Pep-1 in terms of transport efficiency when using vesicles as
membrane models [88]. A possible explanation for increased efficiency is that guanidinium groups
show higher affinity than lysine for hydrophobic anions. Interestingly, this system enabled the study
of defined, independent variables introduced on demand [88].
Peptoids are reported to be protease-resistant alternatives to well-known CPPs [89,90].
Peptoids are peptidomimetic molecules in which the side chain is introduced on the nitrogen atom of
the peptide chain rather than on the α-carbon. Peptoids do not tend to assume secondary structures as
the backbone amine groups are substituted and therefore not able to participate in hydrogen bonding.
Nevertheless, examples of cell-penetrating peptoids (CPPos) have been reported [90]. Depending on
the interplay of charge and lipophilicity, the cellular uptake/endosomal release efficiency of peptoids
and specific organelle (e.g., mitochondrial) localization has been achieved when a lipophilicity
threshold was reached. Some authors argue that the introduction of novel cationic side chains other
than lysine and guanidine in the structure of peptoids would increase their performance [89]. For this
purpose, peptoids containing polyamines, aza-crown ethers, or triphenylphosphonium ions were
designed [89]. These novel CPPos showed stability against enzymatic degradation, in addition to
cell-penetration properties.
Interestingly, Kelley and co-workers described an example of CPP design to obtain peptides
with mitochondrial localization [91]. Two main parameters were included in the design of
MPPs (mitochondria-penetrating peptides), which have a positive charge and lipophilic character.
Positive charge was introduced through lysine and arginine while phenylalanine and cyclohexylalanine
were used to provide lipophilicity [91]. The increased lipophilicity of the triple charged CPPs was
the driving force for mitochondrial rather than nuclear localization. A lipophilicity threshold (log P
values higher than −1.7), as well as a charge-lipophilicity balance, was essential for mitochondrial
localization. When compared to Tat, the same penetration efficiency was observed but with differential
intracellular localization, being nuclear or mitochondrial. Recently, a review on MPPs was published
by the same group [92].
Cell-penetrating polydisulfides. A conceptually innovative way for improving cell penetration
is the use of cell-penetrating polydisulfides (CPDs) [93]. Polydisulfides, obtained by ring-opening
disulfide-exchange polymerization, are guanidinium-rich compounds in which the peptide backbone
is replaced by a polydisulfide one [94]. The topic has been reviewed in detail elsewhere [13]. Briefly,
CPDs are interesting as they are involved in dynamic covalent chemistry on the cell surface and
enter cells by thiol-mediated uptake (Figure 3c) [94]. The most promising CPDs are those shown
in Figure 3a,b. They are advantageous as they undergo reductive depolymerization by glutathione
upon cell internalization (Figure 3c) and do not get trapped in endosomes. They are able to enter
HeLa and MCF-7 cells and efficiently deliver proteins [95]. Their uptake was determined by flow
cytometry at a concentration of 500 nM. In addition, it has been observed that they show identical
intracellular localization, regardless of whether they carry a cargo, thereby suggesting that their cell
penetration is not perturbed by the presence of large biomolecules [95]. An increase in CPD length
affects depolymerization kinetics [96], which in turn also influences their preferential intracellular
localization in endosomes, cytoplasm and nucleoli. This system was further developed to obtain
double-labeled CPDs with a FRET pair at opposite ends of the polymer. These CPDs were shown to
enter cells, although they were split into two fragments at the outer leaflet of the membrane during
uptake [94]. For a comprehensive overview of this topic, please refer to the review by Matile and
co-workers [13].
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guanidinium groups and a polydisulfide backbone, taken in part, with permission from reference [13]
(Copyright © 2015, Royal Society of Chemistry). (c) Schematic representation of the polydisulfide
dynamic covalent chemistry on the cell surface and their cell entry by thiol-mediated uptake,
followed by reductive depolymerization by glutathione (ke = rate of endocytosis, kt = rate of
translocation, kd = rate of depolymerization, kn = rate of nuclear uptake), taken from reference [94].
The role of hydrophobicity nd aromaticity. In addition to cationic moieties, lip phil ones
are also important fo cellular uptake [97–99]. One proposed mechanism implies that hydrophobic
counterions form around the guanidinium-rich backbone of CPPs [98]. The counterion effect was first
shown as the hydrogen bonding interaction between arginine residues and membrane components,
to form complexes that are able to cross membranes [86,100]. This strong bonding of counterions
was not observed for lysine-rich peptides, thereby highlighting the relevance of the guanidinium
group (Figure 4a,b) [87,100]. The formation of the counterion complexes by the hydrophobic parts
of the CPP sequence is referred to as the self-activating property of these peptides [98]. Therefore,
studies exploring hydrophobicity, but also individual aliphatic (Figure 4c) and aromatic (Figure 4e)
functionality contributions, were needed. Some studies n CPP mi ics confirmed that aromatic
activators outperform aliphatic ones [97,101].
Hydrophobicity can be achieved by adding aliphatic or aromatic moieties. On the one hand,
lipidation is obtained by attaching hydrocarbon chains of different lengths to the N-terminal of known
CPPs [39]. Alkylation is a conventional way to increase internalization through enhanced hydrophobic
interactions with the membrane [39,65,82]. Hydrophobicity can also be introduced by incorporating
amino acids with alkyl side chains into the peptide sequence. By introducing alky moieties of different
lengths into CPP mimetics, Tew and co-workers reported a three-fold improvement in activity when
moving from methyl to butyl sid chains [98]. Figu e 4c shows a list of the alkyl chains used for that
study. Interest ngly, when silaproline (γ-dimethylsila-proline) was used instead of proline to obtain
a new polyproline PPII helical CPP, better internalization efficiency was observed. According to the
authors, this observation is attributable to the overall increase in hydrophobicity [79].
Alternatively, hydrophobicity can be achieved by adding aromatic amino acid residues, such as
tryptophan, phenylalanine and tyrosine [97]. These side chains also account for the contribution
of aromaticity. According to Wimley and White, aromatic residues have favorable free energies of
insertion at the bilayer interface [99]. To study the introduction of both aliphatic and aromatic amino
acids in CPP design, CPP mimics were used to report on individual contributions, i.e., hydrophobicity
or aromati ity. As previously reported, the mimics were obtained by ring-opening polymerization.
Pyrene, c ronen and fullerene were shown to trigg r guanidiniu ion activatio , thereby allowing
the passage of CPPs across membranes and an increase in the uptake of polyarginines [101]. Later,
the specific role of aromatic functionality compared to overall hydrophobicity was confirmed by Tew
and co-workers [97]. The authors designed a new series of CPP mimics to determine whether the
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aromatic functionality provides better transduction efficiency than the aliphatic one, while maintaining
the same relative hydrophobicity [97].
Aromatic functionality was found to contribute to CPP internalization. Because aromatic groups
have the ability to π–π stack with membrane proteins containing aromatic residues, they may contribute
to promoting and/or stabilizing the interactions of CPPs with membranes and help translocation.
In this regard, π–stacking was studied on vesicle-based models [81]. This concept was extended
to the analysis of the influence of various π-interactions (π–π, π–cation, π–anion, and π–polar)
on the internalization. For this purpose, monomers containing aromatic rings substituted with
electron-donating and -withdrawing groups were used to show the effect of changes in quadrupole
moments on these systems [81].
The examples mentioned reflect the versatility of design possibilities of the primary structure, i.e.,
at the sequence level. When introduced in a programmed manner, these design strategies contribute to
elucidating the individual structural components necessary for uptake.
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Figure 4. Schematic representation of the (a) bidentate and (b) monodentate hydrogen bonding
interaction of the guanidinium group of the arginine and of the lysine side chain, respectively,
with the membranes, taken in part from reference [87]; (c) Example of CPP mimetics containing
a combination of guanidinium and aliphatic groups of various lengths (from methyl to dodecyl),
used to improve internalization efficiency by mimicking the hydrophobic counterion effect (reproduced
with permission from refere ce [98], Copyright © 2011 Wiley) (d) Example of CPP mimetic based
on the incorporation two gu nidines per repeat unit synth sized for a comparison study with a
lysine-rich CPP, Pep-1, aken in part, with permission from refere ce [88] (Copyright © 2015 Elsevier);
(e) Examples of aromatic functionality introduced in guanindine-containing CPP mimetics, including
octyl, cyclohexyl, phenyl, naphthyl and pyrenyl (DP = degree of polymerization, Mn = apparent
molecular weight, Mw/Mn = polydispersity index), reproduced with permission from reference [97]
(Copyright © 2012 Wiley).
Chirality. The susceptibility of conventional CPPs based on natural L-amino acids to proteases
is a major drawback for their application in vivo. Various strategies to increase stability have been
introduced in the design of the primary structure of CPPs. These are based mainly on the use of
non-natural amino acids, such as all D-stereoisomer versions of CPPs and more recently on L- and
D-combinations [102–104]. Cyclization has also been explored in th se terms [105]. Results showed
that D-peptides were efficient in increasing stability; however, they had similar or often lower CPP
efficiency. Zhang and co-workers showed that the internalization efficiency is affected by the number
Molecules 2017, 22, 1929 11 of 38
of D-arginine residues in the peptide sequence [102]. It has also been observed that the uptake of L-
versus D-amino acid CPPs occurs in a cell-dependent manner and that it is dependent on two factors,
namely heparin binding and initiation of internalization [106]. Brock and co-workers explained that
chirality has an effect on the initiation of internalization in selected cell types, thereby providing useful
knowledge for potential future stereochemistry-dependent targeting of cells [106]. Another report
showed that multiple substitutions of L- to D-amino acids alter the internalization efficiency of anionic
and amphipathic CPPs in a cell-dependent manner and that the position of D-substitution within the
peptide is a key parameter [104]. Interestingly, when the D-substitution was responsible for altering
the α-helix to β-sheet ratio of anionic CPPs, cell entry was altered [104]. In addition, the uptake
efficiency effect of all D-stereoisomers was shown in vivo by Giralt’s group, where polyproline-based
CPPs exhibited enhanced protease-resistance and similar internalization behavior compared to all
L-versions [103].
The contribution of chirality to internalization efficiency remains unclear; however, the main
advantage of using D-stereoisomers in CPP design is proteolysis resistance. Similar penetration profiles
of all D-stereoisomers might be achieved through longer exposure times.
4.2. Flexible Amphipathic CPPs
Since the early 1950s, when Pauli, Corey and Crick elucidated secondary structures such as
β-sheets [107] and β-hairpins, α-helices and coiled coils in proteins [108], great advances have been
made in the understanding of protein folding. The distinct natures of amino acid side chains determine
protein behavior and folding characteristics.
α-Helical secondary structures (Figure 5c) form when the peptide backbone of a single amino
acid chain coils as a result of repeating backbone dihedral angles (Figure 5a). In this conformation,
each amino acid residue hydrogen bonds with the amino acid residue, which is four positions further
along the chain. Assemblies based on α-helical conformation are characterized by an α-helical coiled
coil motif with the repeating heptad unit (abcdefg)n, where each letter indicates a precise position and
accommodates a specific amino acid type (Figure 5b) [109,110]. In a and d, which stand for positions
one and four respectively, only hydrophobic amino acids can be accommodated, thus creating the
required spacing between hydrophobic units. The fifth and seventh position (e and g), closely located
on neighboring helices, usually contain oppositely charged amino acid residues. This electrostatic
attraction can contribute to the stabilization of the helices. The other three positions (b, c and f ) are the
solvent-exposed residues and they have fewer restrictions, thus several residues can be explored for
them. α-Helical antimicrobial cationic peptides that tend to assume a bioactive helical conformation
when in contact with cell surfaces are an example [111]. Administered as soluble inactive forms,
they fold when in contact with negatively charged membranes. In addition, well known CPPs,
such as Pep-1, MPG, TP10 and SAP, were shown to adopt inherent helical structures or assume helical
conformation when in contact with cell membranes (Figure 5g) [112]. Their folded states promote
membrane permeation [80].
Polyproline helices PPI and PPII are a type of protein secondary structure composed of repeating
proline residues (Figure 5d) [113]. They consist of all cis or all trans conformations of the peptide bond,
respectively. The PPI helices form preferentially in organic solvents and are right- handed. On the other
hand, when exposed to aqueous environments, polyprolines tend to form left-handed PPII helices.
Interestingly, PPII helices have cell-penetration properties [114].
In proteins, β-sheet-like secondary structures are dominated by inter-chain hydrogen bonding
between closely aligned carbonyl and secondary amino groups on the peptide backbone. They can
be formed by proteins, peptides of de novo design, β-hairpins, and aromatic and aliphatic peptide
amphiphiles. The formation of β-sheets can occur in two ways. Parallel β-sheets form when the
direction of each N (N-terminus) to C (C-terminus) peptide backbone is in the same direction (Figure 5f).
Anti-parallel β-sheets are observed when the peptide backbones are parallel but the direction of the
peptide chains alternates, going from N to C and from C to N (Figure 5e).
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In short peptide sequences, β-sheet formation can be obtained by alternating hydrophobic
with hydrophilic residues, by introducing aromatic moieties, or by basing the design on known
β-sheet-forming moieties. β-sheet-forming peptides based on EAK and RADA peptide sequences,
where hydrophobic amino acids residues are alternated with hydrophilic charged ones, have been
studied primarily for regenerative medicine applications [115–117]. Peptides that spontaneously form
β-structures when in contact with cell membranes have been proposed for anticancer applications.
Based on knowledge of antimicrobial peptides, Schneider and co-workers presented a cationic
peptide (SVS-1) that disrupts cancer cell membranes by exploiting their aberrant phospholipid
distribution [118]. This peptide was observed to fold on the surface of cancer cells while it remained
unfolded in aqueous solution. It is capable of disrupting the membrane only by adopting the
amphiphilic, β-hairpin structure. This membrane-induced folding, driven by the electrostatic
interaction between the positively charged peptide and the negatively charged membrane surface of
cancer cells, is essential for its anticancer activity [118].
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Figure 5. Schematic representation of (a) primary peptide sequence with dihedral angles; (b) heptad
units: (abcdefg)n where the a and d (green) are hydrophobic amino acids, e and g (orange and red)
are oppositely charged amino acid residues, and b, c and f (blue) represent the solvent-exposed
amino acids; (c) α-helix structure indicating hydrogen bonding; (d) Structures of PPI and PPII
reprinted with permissio from reference [113] (Copyright © 2017, American C emical Society);
schematic representation of (e) anti-parallel and (f) parallel β-sheets found in proteins and synthetic
peptides. (g) Schematic representation α-helical or β-sheet folds that form upon the interaction of
CPPs with membranes, where even small changes in the primary sequence result in different folding
behavior, reproduced with permission from reference [112] (Copyright © 2010, American Chemical
Society).
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Folding and secondary structure of CPPs to control translocation. Two main parameters to
be considered when studying the effect of secondary structures on CPP translocation efficiency are
(a) affinity of CPPs for membranes and (b) their folding capacity in the presence of membranes.
These two parameters are interconnected as they are based on the same principle of weak interactions.
Their contribution is essential to understand the driving forces of CPP internalization and to improve
the design of future CPPs. As already mentioned, the CPP-phospholipid interaction in membranes is
based on the interplay of weak interactions, namely electrostatic interactions, hydrophobic effect and
hydrogen bonding. As a result of these interactions, CPPs often fold and assume secondary structures.
Their ability to fold is also closely related to their amphipathic nature. The folding properties (inherent,
i.e., primary sequence-related or membrane-induced) of CPPs have been studied in detail in membrane
models to better understand the role of the interfacial properties and conformational state of these peptides
on internalization efficiency. Adsorption experiments at the air–water interface imply that α-helical-
and β-sheet-like peptides differ in amphipathic character [15]. Helical CPPs were found to be more
amphipathic than β-sheet ones. In addition, it has been noted that internalization may differ in function
of amphipathicity [15].
Swiecicki and co-workers rationalized the affinity of CPPs for the membranes based on peptide
amphipathicity [9]. They reported on translocation mechanisms of well-known CPPs, such as penetratin,
Tat, R9, R6/W3 (RRWWRWRR), Pep-1 and TP10 (AGYLLGKINLKALAALAKKIL) using vesicles as
model membranes [9]. All examples described were based on cationic peptides with charges from +4 to
+9 that show variable or no amphipathicity. The following CPP classification into three subgroups was
proposed: primary amphipathic, secondary amphipathic and non-amphipathic. Primary amphipathic CPPs
(pep-1 and TP10) are characterized by a primary peptide sequence where hydrophobic and cationic
residues are segregated at the primary structure level. On the other hand, secondary amphipathic
molecules, such as penetratin and R6/W3, are made of hydrophobic and cationic residues that have
an amphipathic character only when the CPP is in the folded state. When in α-helical conformation,
secondary amphipathic molecules are able to expose the hydrophobic and the cationic side, while this
repartition of the residues is not achieved at the primary sequence level. Finally, the unstructured
group comprises polycationic CPPs such as R9.
An example of a tryptophan-rich secondary amphipathic CPP is CADY (sequence:
Ac-GLWRALWRLLRSLWRLLWRA-cysteamide). This 20-mer was designed by combining aromatic
tryptophan and cationic arginine residues into a secondary amphipathic CPPn [119]. When in contact
with cell membranes, it adopts a helical conformation by exposing hydrophobic residues on one side
and the cationic ones on the other side of the helix.
Divita and co-workers studied the structural state and conformational plasticity of 10 well-known
CPPs in various environments (membrane models) [15]. They observed α and β structures in
the presence of phospholipids. The ability of CPPs to interact with membranes via electrostatic
interactions often triggers conformational transitions from random coil disordered states to more
organized α-helical or β-sheet conformations [35]. Therefore, on the basis of their capacity to form
secondary structures in the presence of phospholipids, CPPs were divided into the following subgroups:
(a) random coils, (b) β-structures and (c) α-helical conformations [9,15]. The main structural transitions
that occur when CPPs are exposed to new environments (presence of phospholipids) have been
summarized elsewhere [9,15]. Briefly, Tat and R9 are unstructured in buffered solutions, while other
CPPs (Penetratin, R6/W3, Pep-1 and TP10) show mixtures of conformations or low levels of secondary
structure. At high concentrations, only Pep-1 presents a helical conformation in water.
Since Tat and R9 are of hydrophilic polycationic nature, they remain unstructured regardless
of the environment, and they translocate as random coils. R6/W3, Pep-1 and TP10 are in the helix
group as they are random coils in the presence of zwitterionic phospholipids but can fold to form
helices in the presence of negatively charged phospholipids. These peptides translocate when in
helical conformations. Penetratin is random coiled in the presence of zwitterionic phospholipids.
However, its behavior is determined by experimental conditions, i.e., phospholipid charge density
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and CPP/phospholipid ratio. Penetratin is part of the β-sheet group as it undergoes a random coil to
β-sheet transition at high CPP/phospholipid ratios. In addition, it was found to fold into helices in the
presence of low amounts (20%) of anionic head groups and to transition from α-helical conformation
to β-sheets when the ratio of CPP/phospholipid or negative phospholipid content increases [120].
The structural polymorphism of penetratin and transportan was examined using
Boltzman–Stochastic algorithms to assess the influence of the environment on their behavior
in proximity to membranes [121]. For this purpose, models were developed for hydrophobic and
hydrophilic environments and compared with experimental NMR data. In the case of penetratin,
the tryptophan residues were replaced by phenylalanine to obtain mutants with increased helicity
in a hydrophilic environment. For transportan, deletion analogs were modeled. In both cases,
the structural polymorphism resulted essential for maintaining cell permeability [121].
A specific class of CPPs is based on polyproline secondary structures. Proline presents unique
structural properties as it is the only one of the 20 genetically encoded amino acids to have a
secondary amine chain. For this reason, it does not participate in intra- or inter-molecular hydrogen
bonding. CPPs forming polyproline-type secondary structures were discovered by Giralt and
co-workers [24,122,123]. These CPPs show a common (VXLPPP)n general structure [123]. A library
of polyprolines was synthesized to study the effect of primary and secondary amphipathicity on
penetration efficiency ((VXLPPP)n with X = H, K, R; n = 1,2,3) [79]. It was concluded that internalization
of such compounds is due to the amphipathicity of the secondary structure rather than of the primary
sequence. The best performing CPP was (VRLPPP)3 and it was named sweet arrow peptide [24].
To increase its efficiency, modifications were introduced by adding fatty acid moieties to the N-terminus
of the sequence [39] or by mutating one of the prolines to a silaproline [79]. In addition, an all D-version
of the sweet arrow peptide was prepared to obtain CPPs with greater resistance to proteases [103].
A chemically modified version of the sweet arrow peptide (VRLPPP)3, in which arginine was
replaced by glutamate residues, presents PPII helical secondary structure and carries a net negative
charge. Surprisingly, this first-in-class anionic CPP exhibits the same cell-penetration activity as
SAP, its cationic counterpart [124]. In addition, when the Ac-CGGW sequence was added to the
N-terminus of SAP(E) as a binding motif, immobilization to surfaces or attachment to biologically
active substances was achieved [125]. This modification did not influence the uptake rates of the
peptide, and the internalization was due to polypeptide aggregation on the cell surface, followed by
endocytic uptake [125]. The studies were based on model membranes in both lipid mono- and bi-layer
configurations. It was found that the initial binding is induced by structural changes of the peptide (in
bulk, it assumes a PPII helical structure that undergoes a structural transition at membrane interfaces
either by refolding or self-aggregating) [125].
Interestingly, a β-strand-forming CPP based on the γ-polyproline backbone was reported [126].
After designing a non-natural proline-derived γ-peptide backbone using a cyclic conformationally
constrained cis-γ-amino-L-proline as monomer, γ-peptides with the ability to adopt secondary structure
in solution were obtained. The secondary structures identified by both NMR and CD analysis suggested
the formation of an isolated H-bond ribbon, resulting in a short β-strand [127]. Alkylated, acylated and
guanidinylated variants were examined for their capacity to enter cells. CPPs with the ability to enter
cells via endocytic pathways were obtained by functionalizing the α-amine with amino acid side
chains such as alanine, leucine and phenylalanine. These new unnatural short oligomers showed
improved solubility, protease resistance, and lower toxicity when compared to Tat [126].
Helicity induction or stabilization through sequence design. Unlike the examples based on
unstructured CPPs that adopt a bioactive conformation when in contact with cell surfaces, helicity can
be obtained through the design of primary sequences. Helicity can be programmed into the primary
sequence by using a natural non-coded α-aminoisobutyric acid (Aib) [128]. CPPs that contain Aib,
often used to stabilize peptide helical structures, at the primary sequence level were reported [129].
To gain knowledge on the control of the secondary structures of these short peptides, the authors
developed a number of amphipathic nonapeptides containing L-Arg, D-Arg, and the achiral Aib
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residues (Figure 6a). They observed that the helical structure contributed to the ability of the peptide
to cross membranes. The peptides that formed stable α-helical structures were more efficiently
internalized into Hela cells than the non-helical ones [129].
To assess whether the CPPs are able to change their secondary structure in response to the
environment, this study was extended to the introduction of L-proline or the modified guanidinyl
L-proline (Figure 6b). In this regard, modular CPPs were designed based on the ability of proline
residues to sense environments (hydrophilic and amphipathic) [130]. The authors reasoned that
the conformational change from random coil to helical structure when in contact with membranes
contributes to enhanced endosomal escape. The peptide with the best performance, namely the one
containing guanidinium-modified L-proline, was further explored for plasmid DNA transport into
HeLa cells [130].
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As previously mentioned, guanidiniu -rich peptides lack the ability to fold and adopt helical
structures. Therefore, polyarginines adopt a random coil configuration at physiological pH.
Interestingly, when both helicity and hydrophobicity are included in their design, helical arginine-rich
mimics are obtained, showing membrane activity two orders of magnitude higher than that of Tat [80].
Polyarginine analogs with a polypeptide backbone obtained via ring-opening polymerization and
designed to contain guanidinium side chains placed at fixed distances from the peptide backbone
were shown to adopt a stable α-helical conf rmation [80]. The addition of alkyl chains o different
lengths (using click chemistry) led to alterations of hydroph bicity. Higher alkyl chain content,
from –C3H7 to –C6H13, resulted in enhanced helical propensity, which contributed to enhanced
membrane permeability (Figure 7a) [48].
The importance of the concomitant effect of helicity, polypeptide backbone length and side chain
hydrophobicity on membrane permeability was reasoned. The helical polyarginine mimics were
labeled with rhodamine and their membrane permeability in carcinoma (HeLa) cells, fibroblasts
(3T3-L1) and macrophages (Raw 264.7) was examined. These helical mimics outperformed the cell
penetration efficiency of Tat and R9 by 1–2 orders of magnitude, as determined by spectrofluorimetry,
and ere abl to deliver DNA and siRNA to mammalian cells. This example shows how helicity
stabilization (seconda y structure) through primary sequence mod fication is a useful approach to
obtain CPPs with igher activity [80].
Based on the principle of polyproline folding, small proteins with intrinsic cell-permeability can
be designed. These small proteins (36-residue polypeptides) with minimal cationic content within a
PPII-type helix can cross membranes [47,131]. They can be stabilized by reducing the cationic content.
Therefore, a minimal content of arginine residues has to be found that guarantees cell permeability
while preserving protein stability. In this design strategy, the arginine residues were located on the
solvent-exposed side of PPII helices.
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Similarly, Futaki and co-workers designed a helical CPP by developing analogs of a cationic
cytolytic peptide that presents helical secondary structure, already described in the endosomal escape
section [69]. The goal was to maintain helicity while reducing the positive charge by replacing small
hydrophobic residues such as leucine, glycine or alanine in the hydrophobic part of the amphipathic
helix with glutamic acid ones (Figure 7b) [69].
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4.3. Rigidity as an Emerging Concept in CPP Design
There is a concentration threshold, influenced by sequence length, that promotes one
internalization route over another [21,38]. Similarly, the structure of the scaffold is important to achieve
optimal spatial distribution of guanidinium groups for multivalent interaction with membranes.
Cyclization is a means of maximizing membrane contacts as it leads to a more controlled distribution
of positive charge when compar d to free arginines prese t on linear CPPs [132]. Cyclization has
been shown to increase the kinetics of Tat internalization (cycl c Tat vs. linear Tat) [21]. In addition,
multivalency has been introduced using dimerization and transient (reversible) cyclization through
di-sulfide bonds or triazole bridges [49,133–135].
Head-to-tail cyclization. It has been proposed that cyclization can be used to confer greater
proteolytic resistance and increased penetration efficiency [21,49,60,105,133,136–138]. Parang and
co-workers reported a study on 11 amphipathic cyclic peptides composed of hydrophobic (W, F, L) and
charged residues (K, R, E) to obtain an optimal amphipathic CPP able to undergo intramolecular and
intermolecular interactions [136]. All the combinations evaluated were homochiral L-cyclic peptides.
The best internalization results were obtained with [WR]4 (Figure 8b) and [WR]5. These peptides
were further analyzed as delivery tools for a peptide template and a model drug (doxorubicin).
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The peptides did not show cytotoxicity up to 50 µM (MTT) in a leukemia cell line (CCRF-CEM),
colon adenocarcinoma (HT-29), breast carcinoma (MDA-MB-468) or human ovarian adenocarcinoma
(SK-OV-3).
An example of the use of cyclization to introduce greater peptide structural rigidity was reported
by Cardoso and co-workers [21]. In that study, the efficiency of a retro-enantio version of linear
Tat (rrrqrrkkrg) and R10 to enter living mouse myoblast cells was compared with that of cyclic Tat
(K-rRrQrRkKrG-E) (Figure 8c). In the structure of cyclic Tat, K- and E- amino acids were added to the
linear Tat sequence to allow cyclization and obtain a ring with the same overall charge as the native
form. This resulted in improved transduction kinetics of arginine-rich cyclic peptides, which presented
lower degrees of freedom when compared to the linear counterparts that have higher flexibility.
In addition, cyclization caused the guanidinium groups to remain in maximally distant positions and
assume a controlled spatial distribution within the structure. This resulted in enhanced contacts with
the membrane and therefore faster penetration. Previously, introducing spacers such as glycines into
polyarginine CPPs and thus increasing the distance between guanidinium groups led to improved cell
permeability [139]. Similarly, this approach allows the distances between guanidinium groups to be
increased, but without the need to modify peptide sequences responsible for cell penetration [21].
Pei and co-workers presented another example of cyclic arginine-rich CPPs internalized by
endocytosis [60]. These compounds showed higher proteolytic stability compared to Tat and R9.
Their cellular uptake increased upon cyclization [60]. Cyclic peptides with a general formula (cFΦR4,
where Φ stands for L-2-naphthylalanine) were synthesized using varying design parameters, such as
sequence lengths, stereochemistry or a combination of the two. Cellular uptake efficiency in HeLa cells
was assessed by flow cytometry. All the analogs showed internalization properties. From this study,
it was concluded that two aromatic and three arginine residues were enough to obtain functional CPPs
(Figure 8a). However, the uptake efficiency was also closely related to the specific peptide sequence.
Cyclization, and therefore the introduction of structural rigidity, most probably led to the achievement
of a proper spatial arrangement of guanidine groups and hydrophobic side chains, which were critical
for internalization efficiency. Furthermore, pharmacokinetic studies were performed in vivo following
intravenous injection or oral administration of cFΦR4 CPPs in ICR male mice. Oral bioavailability of
4% was observed, thereby confirming their metabolic stability and opening up possibilities for oral
delivery [60].
Similarly, Nielsen and co-workers designed changes in a natural product based on the cyclic
heptapeptide sanguinamide A in order to increase its oral bioavailability [105]. The optimization was
based on NMR studies. L-amino acids, namely phenylalanine, alanine, isoleucine, two prolines and an
isoleucine-thiazole dipeptide derivative, were used to obtain a rigid scaffold through the formation of
the heterocycle. Rigidity was further reinforced through bulky hydrophobic (tertbutyl glycine) side
chains and by favoring intramolecular hydrogen bonds. The introduction of constraints resulted in
greater oral bioavailability in rats [105].
A combinatorial library approach was used to discover cyclic peptides with increased cell
permeability [137]. A library, inspired by natural products, of more than 1000 compounds based on
cyclic hexapeptides with a general structure Pro-(Xaa)4-Tyr was prepared (Figure 8d). Stereochemistry
and N-methylation were the two parameters used to obtain backbone geometries that resulted in
different conformational preferences. L- and D-Leu and Me-Leu amino acids were explored in positions
X2–X5. By introducing amino acids with variable side chains in X positions, the effect of lipophilicity
and backbone flexibility was assessed. It was found that side chain orientation and steric factors
drive the internalization properties of these cyclic CPPs. The advantage of this study is the possibility
to explore the relationship between conformation and cell permeability. Although it constitutes an
interesting example of cyclic CPPs, their permeability (passive diffusion) was assessed by PAMPA
assay only. Activity comparison with standard (classical) CPPs has not been reported for this set of
CPPs to date [137].
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Figure 8. (a) Example of the design of cyclic CPPs containing different domains, such as repeating
arginine units, a hydrophobic region to facilitate membrane interactions, and a target binding region
(reprinted with permission from reference [140], Copyright © 2013, American Chemical Society);
(b) Chemical structure of a different example of cyclic CPP design, based on alternating arginine with
tryptophan residues, with the [WR]4 candidate showing the best performance, used with permission
from reference [136] (Copyright © 2011 Wiley); (c) Phase contrast and confocal images of live-cell
transduction ability of fluorescently labeled CPPs: PTD4, Tat, R10 and cyclic Tat were internalized into
living mous myoblast cells with different efficiency, cyclic Tat bei g the most effici nt (t ken from
reference [21], Copyright © 2011, N ture Publishing Group); (d) G neric structure of he library of
geometrically diverse cyclic hexapeptides (based on L- and D-stereoisomers), reprinted with permission
from reference [137], Copyright © 2015, American Chemical Society.
Interestingly, the triazole bridge was proposed as a means to control the penetration of cyclic
peptides into membranes [49]. Three cyclic peptides were obtained by cyclization of a previously
developed linear CPP, called sC18 (sequence: GLRKRLRKFRNKIKEK), which is based on CAP18
(sequence: GLRKRLRKFRNK) antimicrobial peptide. In sC18, glycine and lysine residues were
replaced by propargylglycine and ε-azidolysine, respectively, to allow cyclization by copper-mediated
click chemistry. Triazole bridges were introduced to explore whether secondary structure arrangements
could be promoted. sC18 was classified as seco dary amphipathic as it assumed α-helical conformation
when in con act with artificial lipi membranes [49]. The three cyclic peptides developed differed in
the number of argi ine residues present within the cyclic structure. In this regard, the influence of
spatial distribution of guanidinium groups was explored. Cyclization was obtained by connecting
residues at positions 1 + 4, 1 + 8 and 1 + 12 of the linear peptide. The synergistic contribution of
backbone rigidification and static arrangement of the guanidinium groups (arginine side chains),
together with the conformation, were expected to contribute to enhanced internalization. The peptides
were non-cytotoxic in the concentration range of 2–200 µM for breast adenocarcinoma (MCF-7),
colon adenocarcinoma (HCT-15), cervical carcinoma (HeLa) and embryonic kidney (HEK-293) cell
lines. Their increase uptake depended on the ycle size, with the larg st cycle showing the highest
membrane activity. Therefore, the 1 + 12 cyclic peptide was used for the delivery of plasm d DNA
(in the form of complex), proving to be efficient in transfecting MCF-7 cells.
Disulfide bridges and bicyclization. When cFΦR4 CPPs were developed, two types of cyclization
were proposed. Originally, N-to-C cyclization was reported (Figure 8a) [140]. In addition,
cyclization through an intramolecular di-sulfide bond was proposed by modifying the sequence
to contain two cysteine residues (Figure 9a) [133]. Both versions were efficiently internalized by
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HeLa cells and were able to escape endosomes. The advantage of the latter strategy was the
reversibility of the cyclization in a reductive environment and increased proteolytic stability. Moreover,
Pei and co-workers proposed a bicyclization strategy to increase the uptake of generally impermeable
cyclic peptides [134]. The combinatorial library approach was also put forward for bicyclic CPPs,
where cFΦR4 was fused to over 5 million distinct cyclic peptides to generate a bicyclic cell-permeable
peptide library [134]. An important feature of the library design was the use of a rigid and planar
scaffold such as the trimesoyl group. This allowed the formation of the desired bicyclic structure,
where CPP and cargo moieties were oriented away from each other, thereby minimizing interference.
One ring was the previously reported cyclic CPP (cFΦR4), while the other contained a ligand for K-Ras,
which is a very difficult intracellular target. The general applicability of the cyclization approach
was assessed. Two rings were used, one with CPP properties and the other with having the peptide
sequence (X5) based on 26 amino acids used in different combinations in positions X1–X5 and containing
10 proteinogenic L-amino acids, six unnatural L-amino acids and 10 D-amino acids [134].
Recently, the same group has reported on a reversible bicyclization strategy achieved through
the formation of a pair of disulfide bonds (Figure 9b) [138]. Conformationally constrained bicyclic
structures were obtained with the goal to induce the uptake of generally impermeable peptidyl drugs.
Another advantage of this approach is increased proteolytic stability. The novelty of the design is the
presence of a small CPP ring for enhanced uptake, in addition to a cargo ring able to accommodate
peptides of various lengths. For this purpose, two model peptides containing two cysteine residues
were designed (RRRRΦF and FΦRRRR). One cysteine was positioned at the C-terminus while the
other was placed at the fusion point between the CPP and the cargo. Cyclization was performed
on-resin between the two cysteine side chains and the 3,5-bis(mercaptomethyl)benzoic acid was used
as a scaffold to obtain a single bicyclic structure. This scaffold was chosen because of its symmetry.
Flow cytometry analysis of HeLa cells showed that bicyclic peptides had a greater capacity to enter
cells than the CPP cFΦR4, which holds only one cycle. Interestingly, the in vitro treatment of these
bicyclic peptides with glutathione led to reduction of disulfide bonds. This observation suggests that
these peptides would undergo reduction upon cell penetration [138].
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obtained through bis-Fmoc protected lysine near the C-terminus. Cargo (Cyanine 5) was introduced on 
the lysine side chain at the C-terminus residue. The uptake in HeLa cells was determined using flow 
cytometry and compared to that of R8, penetratin and linear Tat. The novel branched peptide showed 
enhanced uptake compared to the controls. Importantly, the non-linear dependence on concentration 
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Figure 9. Schematic representations of reversible (a) cyclic (cyclization through a disulfide bridge) and
(b) bicyclic (cyclization through a pair of disulfide bonds) CPPs that undergo reduction upon exposure
to glutathione in an intracellular environment, used with permission from references [133] (Copyright
© 2015 Wiley) and [138] (Copyright © 2017 Wiley), respectively.
Multivalency. An ther parameter to consider is the multivalency of the system. One step in this
direction is th development of imeric br nched peptides, as sh wn by Salud s and co-w rkers [135].
The c v lent dimeric branched pep i e was d sign d as an analog of Tat. Controlled dimerization was
obtained through bis-Fmoc protected lysine near the C-terminus. Cargo (Cyanine 5) was introduced on
the lysine side chain at the C-terminus residue. The uptake in HeLa cells was determined using flow
cytometry and compared to that of R8, penetratin and linear Tat. The novel branched peptide showed
enhanced uptake compared to the controls. Importantly, the non-linear dependence on concentration
and uptake at sub-micromolar concentrations was observed for the dimers. In addition, the dimers
were non-cytotoxic to Hela cells at a concentration up to 50 µM. A similar trend was observed in
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primary hippocampal neuronal cells. This example shows how the introduction of multivalency can
improve CPP peptides [135]. In addition, the ability to cross membranes may have been promoted as a
result of increased local concentration on the membrane surface in a synergistic fashion.
Extended peptides based on oligoarginines were developed through disulfide bridge formation.
Based on the knowledge that polyarginines need a minimum number of residues (at least 6) to cross
membranes, Lowik and co-workers designed small inactive oligoarginine fragments (R4) that could be
activated by linkage through C-terminal cysteines with R4 or R5 sequences [141]. Cellular uptake in
Hela cells was determined by flow cytometry for 5 µM and 20 µM concentrations. The uptake was
similar to that of the control R8 and R9 peptides. Important parameters such as oligoarginine length,
concentration and position of disulfide bridges (structural arrangement of arginines) were essential to
improve efficiency and influence the mechanism of uptake. Symmetric distribution of guanidinium
groups led to more efficient CPPs.
Conformational restriction. As described previously, helix stabilization can be achieved by
adding alkyl chains or by including α,α-disubstituted amino acids such as Aib into poly(arginine)
mimics in the primary sequence design [80,128,129]. In addition, stabilized helices can be obtained by
covalent bond formation between two side chains of short peptides. Examples are disulfide bonds,
stapling, and N-terminal aspartic acid crosslinking [142].
First described in 2000 by Verdine and colleagues, stapling consists of introducing all-hydrocarbon
crosslinks into peptide sequences. This is achieved by ring-closing olefin metathesis of
α,α-disubstituted non-natural amino acids that have hydrocarbon tethers [143]. Since then,
peptide stapling has been successfully applied to the study of protein–protein interactions for intra- and
extra-cellular targets [143–145]. The α-helical stabilization achieved resulted in increased resistance
to proteases because the peptide bonds in the interior of the helix were protected. Staples were
also explored in the CPP field as it was observed that some, but not all, α-helical staples are able
to reach intracellular targets. In an attempt to unravel the biophysical properties that drive the
uptake of stapled-peptide libraries, Walensky and coworkers reported on the main parameters to
be included in the design of stapled CPPs (Figure 10b) [146]. Rather than the staple itself, various
factors such as helical stability, increased overall hydrophobicity and positive charge were found to
influence the CPP efficiency [147]. Nevertheless, the presence of the staple was found to improve
hydrophobic interactions with membranes (Figure 10a). Efficient cellular uptake of the stapled peptide,
when compared to the unstapled version, was shown in mouse embryonic fibroblasts (MEFs) at 500 nM
dosing [146].
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Recently, N-terminal crosslinking of aspartic acid has been reported to stabilize the helical
structure [149]. The crosslinking was obtained by simple peptide bond formation between the side
chain of the terminal aspartic acid and the amino group of the 2,3-diaminopropionic acid (Dap) to
obtain a crosslink that shows a similar distance to that introduced through stapling [150]. This method
was optimized for pentapeptides, and cyclization using L- and D-stereoisomers of aspartic acid was
assessed. The introduction of these crosslinks was responsible for the induction or stabilization of
helical conformations. This example is further evidence that the introduction of conformational
constraints can improve cell permeability. This concept was taken further to study the influence
of single amino acid contributions in stabilized helices. Amphipathic helical peptides containing
Trp, Phe and Arg promoted cell penetration in MCF-7 and HEK293T cells when compared to those
containing Lys, His, Tyr and Leu [149].
4.4. Controlled Self-Assembly
The early 1990s saw the emergence of a new field of molecular self-assembly based on synthetic
peptides. In this regard, pioneering work was presented by Ghadiri [151] and Zhang [152].
The supramolecular assembly of molecular building blocks composed of specific peptide chains
is based on the same principles as those found in nature during protein folding. The 20 gene-encoded
amino acids, together with a variety of non-natural ones, provide a versatile toolbox. Today, we know
that synthetic peptides can self-assemble into a variety of nanoscale morphologies, which are directed
by the amino acid sequence [153] and the mode of assembly [154].
The process of molecular self-assembly is based on weak non-covalent interactions such as
hydrogen bonds, electrostatic interactions that involve charged groups, van der Waals interactions,
hydrophobic interactions, and aromatic π-stacking. Nanostructures can form as a result of interactions
between complementary peptide chains that mimic the basic conformational units found in proteins.
A rich chemical and structural diversity can be achieved by designing building blocks composed
of sequences of amino acids (peptides) that can spontaneously assemble into nanostructures with
distinct architectures. This field has experienced rapid growth, and peptide self-assembly is now
increasingly studied for a wide range of applications in biomedicine, including drug-delivery,
diagnostics, tissue engineering, and regenerative medicine [109,110,115,151,155,156]. Although peptide
self-assembly has been exploited for several applications, only recently has this concept been
introduced into the field of CPPs [36,157].
The concept that supramolecular structures can show different biological behavior to that of the
monomers they are made of was introduced by Stupp and co-workers [158]. Moreover, a number of
supramolecular morphologies show the ability to instruct cell death or survival by exerting a range
of effects on cells. More in detail, unlike their soluble unassembled counterparts, supramolecular
materials based on peptide amphiphiles with hydrophobic domains and cationic charge interact with
cells. Supramolecular materials with nearly identical chemical composition can instruct cell death or
survival depending on their β-sheet-forming capacity. Fragments that show better propensity to form
β-sheets assemble into more cohesive fibers, where the structures reinforced by hydrogen bonding
support cell viability. On the other hand, nanostructures based on weaker interactions can promote
the disruption of lipid membranes and thus cause cell death. The authors reported a systematic study
of the effect of hydrophobic collapse, charge and hydrogen bonding on self-assembling morphology
of the peptide and cell viability. Hydrophobicity and cationic charge were found to be essential for
cytotoxicity, as reducing the hydrophobic tail or the overall cationic charge resulted in lower toxicity of
the peptide amphiphiles examined.
In this section, examples of supramolecular CPPs based on intermolecular interaction of
repeating units will be presented. Supramolecular assemblies can offer some advantages over
primary and secondary CPPs. In this regard, these assembles have tunable physical properties,
higher stability, multivalency, and tunable surface functionality, i.e., high local concentration of
positive charge and/or hydrophobicity. In self-assembled systems, multivalency can be achieved
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through two main approaches: main chain or templated, as described in the review by Ulrich and
co-workers (Figure 11a) [132]. Stupp and co-workers achieved precise control of the dimensions
of virus-like nanostructures through molecular self-assembly [157]. Using DNA as a template,
one-dimensional supramolecular structures of precise length and with tunable characteristics can be
obtained (Figure 11b). These nanostructures can carry a range of cargos and show great potential for
achieving cell permeability through precise design [157].
Dong and coworkers introduced the concept of filamentous CPPs (FCPPs) based on cationic
multi-domain peptides, providing examples of supramolecular structure-dependent membrane
activity [36,159]. The supramolecular approach to obtain FCPPs (based on β-sheet structures) was
reported for cationic peptides with generic structure Kx(QL)yKxz or Kx(QW)yKxz. In this case,
supramolecular structures form due to the interplay of electrostatic and hydrophobic interactions
alongside hydrogen bonding among QL/QW repeating units. The supramolecular assembly of these
short cationic peptides into nanostructures with diverse architectures has the advantage of providing
an enhanced local charge density. Supramolecular assembly resulted in dense packing of lysine
residues, giving rise to high local concentrations of positive charge, i.e., multivalent species able to
interact with the cell membrane. This enhanced interaction is beneficial for tuning the membrane
activity of FCPPs through programmable physical properties, stability and surface functionality.
The design was based on combining tryptophan and lysine at the primary structure level to obtain
self-assembly into a variety of nanostructures. Tryptophan was chosen as the hydrophobic aromatic
residue through which to increase contacts with membranes but also to drive the assembly. On the
other hand, lysine was chosen because of positive charge, thus conferring cell penetration and serving
as a DNA complexation moiety. Two molecules with structures K5(QW)6K5 and K10(QW)6 were
compared in that study. A total of ten lysine residues were used but they were distributed in a
different manner along the sequence. The molecule with a single charged domain (ten lysine residues)
at the N-terminus assembled into nanofibrils based on β-sheets, while the other peptide showed
random coils and irregular aggregates. The fibrillar K10(QW)6 showed greater capacity to enter Hela
cells. DNA delivery with this peptide was 200- and 400-fold higher in the HEK293 and HeLa cell
lines, respectively. In this example, the fibrilllar shape of the supramolecular nanostructure with
the precise balance of charge distribution and conformational flexibility, was responsible for higher
uptake [36]. This system was also used to deliver impermeable anticancer drugs. Similar to DNA
delivery, the fibrillar nanostructures promoted higher and faster uptake of doxorubicinin into HeLa
cells. Membrane sensitization was observed, as was increased permeability to doxorubicin caused by
supramolecular structure and charge multivalency [159].
Tryptophan-rich CPPs that assemble into spherical aggregates were reported [160]. Their design
comprised linear, tripodal and dendrimeric tryptophan-rich structures, to promote cell penetration
and drive self-assembly. The dendrimer structure was based on branched lysines and contained
one, three or five tryptophan residues at different geometric locations. Flow cytometry and confocal
microscopy confirmed that the linear version showed the best performance and was thus a candidate
for further investigation for the delivery of hydrophobic drugs [160].
Another example worthy of mention comprises triple helical CPPs obtained by combining
short oligoarginine CPPs (R6 or RRGRRG) with collagen-like folding domains [14]. In this case,
the triple helical conformation was obtained by using (proline-hydroxyproline-glycine)n repeating
units, which are found in collagen. The exterior of the helices was decorated with the CPPs, a process
that led to the accumulation of positive charges, which favored internalization while the helicity
improved resistance to proteases. Internalization efficiency (at a concentration below the 10 µM) was
shown in Jurkat human leukemia cells using flow cytometry, with the R6-containing helix showing the
highest uptake. No uptake was observed when a scrambled version of the helical motif, which was
unable to assume the triple helical conformation, was used [14].
Recently, Azevedo and co-workers reported on a CPP amphiphile (CPPA) system based on
the self-assembly of multidomain peptide sequences. The design consisted of four main structural
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and functional parameters. A hydrophobic palmitic acid (C16) tail that drives the self-assembly into
nanofibers and serves as hydrophobic pocket for hydrophobic drug encapsulation was added at the
N-terminus. Next, a CPP moiety (YTA4, sequence: IAWVKAFIRKLRKGPLG), an enzyme-sensitive
moiety and an RGD-based targeting moiety were included. The system was found to self-assemble
into fibers that are enzyme-responsive and that protect the CPP sequence. It was observed that
RGD drives the accumulation of these fibers in the proximity of the tumor, where they can undergo
enzyme-triggered fiber to micelle transition and consequently enter cells on demand as a result of
exposure of their CPP moiety (Figure 11c). The in vitro evaluation of these nanostructures is needed to
compare their performance in living cells.
An interesting example of quaternary structure and an alternative approach to control the uptake
of oligoarginine-based CPPs was through the formation of host–guest supramolecular complexes
based on anion recognition [161]. In this system, the R8 CPP was conjugated at the N-terminus to
a negatively charged pyranine-oligoglutamic anion (guest) that was encapsulated by the positively
charged polyamine cage (host). The host–guest supramolecular complexes were internalized into Vero
cells and showed endosomal localization. This is an example of cell-penetrating systems in which
structure and function complexity are achieved through simple design choices [161]. In addition,
the cage and the peptide can be covalently modified, thereby opening up the possibility to attach a
range of drugs.
Finally, the recent report from Garcia-Lopez et al. on the design of photo-activatable molecular
machines able to drill through cell membranes illustrates the important role that molecular motors
will have in the future in the field of intracellular delivery [162].
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DNA-templated, supramolecular DNA-peptide 1-dimensional assemblies, with precise control over
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5. Challenges and Future Perspectives
Despite the variety of CPP design approaches currently available, the translation of CPPs to a
clinical setting remains a challenge. From the examples discussed in the text, it can be appreciated that
the CPP field is wide and in continuous development (Table 1). Greater mechanistic understanding
and further development, often with the focus on endosomal escape enhancement, have led to an
increase in design complexity. This includes the development of stable and often multi-domain cyclic
or self-assembled nanostructures. Moreover, selectivity, targeting and high efficiency and environment
responsiveness are sought to obtain programmable, tailored and on-demand systems.
Many researchers have proposed design strategies that allow control over folding, cyclization,
dimerization, stapling, self-assembly and even CPP mimetics with different backbone structures and
properties, thus leading to improvements in internalization efficiency and stability. However, due to
the concomitant involvement of various internalization mechanisms, the heterogeneity of diseases, and
the variety of cell lines available for in vitro studies, there are still no standards through which to rate
the internalization efficiency improvements of one design over another. In addition, the heterogeneity
of cargoes implies a broadening of the parameters to consider when reporting on CPP efficiency
and activity.
In this regard, standardized protocols are needed as well as a greater number of comparative
studies between different classes of newly designed CPPs. Although huge progress has been made in
this field, there is still room for the development of new strategies and approaches.
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Table 1. Examples of CPPs and their sequences, α-carbon stereochemistry, source, design strategy, structural features and development stage.








Virus derived material Unstructured in buffersolutions; random coil In clinical trials [2,3,8,9,15]
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forms helices in the
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phospholipids
In vivo data [8,9,15,22]
4 MPG GALFLGFLGAAGSTMGAWSQP-KKKRKV all-L
Fusion CPP: NLS








forms helices in the
presence of
phospholipids
In vivo data [8,23]
5 Polyarginine(R9, R8)
RRRRRRRRR all-L Design inspired byentry 1 and 2 Designed to be R-rich
Flexible; unstructured;
random coil In clinical trials [8,9,15,18–20,34,56]
6 R6/W3 RRWWRRWRR all-L
Design inspired by
entry 2
Designed to be R-rich
and hydrophobic
Secondary amphipathic,
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Table 1. Cont.
Entry CPP Name Sequence α-CarbonConfiguration Source Design Approach Structural Features
Development
Stage Ref.
10 gH 625 HGLASTLTRWAHYNALIRAF all-L
Natural; based on the
625–644 residues of the
glycoprotein HSV 1
Derived from Herpes





In vivo data [26–30,32,33,166]
11 GALA WEAALAEALAEALAEHLAEALAEALEALAA all-L
Glu-rich an containing
His (imidazole group)






helical structure able to
lyse endosomal
membranes
In vivo data [55,67,68]









linked to a toxin from
the wasp venom
Primary amphipathic;
forms helices in the
presence of
phospholipids
In vivo data [8,9,167]











helical conformation Cell assays [5,102,119]
14 L17E IWLTALKFLGKHAAKHEAKQQLSKL all-L
Natural; inspired by the
spider venom
M-lycotoxin
Designed to contain E
residues in the
hydrophobic part of the
amphipathic helix































α-Helical structure Cell assays [129]
17 Peptide 3 FAM-β-Ala-(RRPGu)3G3 all-L
Designed to contain -L
proline or guanidinyl -L
proline
Pro residue introduced


























PPII-type helix Cell assays [47,131]
19 TATp-D
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L- and D-  
Designed to contain un-
natural, cyclohexylalanine (Fx) 
residues 
Designed to have differential 
intracellular localization 








all-L, all-D or 
combination of  
L- and D-Arg 
Designed to contain Aib, 
natural non-coded amino acid 
Helix stabiliz tion is introduced 
at the primary sequence level α-Helical structure Cell assays [129] 
17 Peptide 3 FAM-β-Ala-(RRPGu)3G3 all-L Designed to contain -L proline 
or guanidinyl -L proline  
Pro residue introduced in order 
to sense hydrophobic and 
amphipathic environments 
Helical structure in 
contact with 
membranes 












Small proteins (36-residue 
polypeptides) 
Arg residues were located on the 
solvent-exposed side of PPII 
helices 
PPII-type helix Cell assays [47,131] 
19 ATp-D 
 
all-L Designed as analogue of Tat 
Covalent dimeric branched 
peptide; dimerization obtained 
through bis-Fmoc protected 
lysine near the C-terminus 
Branched peptide Cell assays [135] 





Extended peptides obtained 
through disulfide bridge 
formation of truncated 
oligoarginines 
Designed as small inactive 
oligoarginine fragments (R4) 
activated by linkage through C-
terminal cysteines 
Branched peptide Cell assays [141] 
Cyclic Peptides 
21 







Designed to contain 
combinations of hydrophobic 
(W, F, L) and charged (R, K, E) 
residues 
Designed to obtain optimal 
amphipathic CPP resistant to 
proteolysis  
Cyclic Cell assays [136] 
22 Cyclic Tat c[K-rRrQrRkKrG-E]c Combination of 
L- and D- 
Lys- and Glu- amino acids 
added to the linear Tat 
sequence to obtain a ring with 
the same overall charge as the 
native form 
Designed to introduce structural 
rigidity and controlled spatial 
distribution of guanidinium 
groups 
Cyclic Cell assays [21] 







Branche peptide Cell assays [135]
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Table 1. Cont.
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linear Tat sequence to
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Cyclic Cell assays [21]
23 cFΦR4 c[FΦRRRRQ]c all-L






combination of the two
Cyclic In vivo data [60,133]
24 Danamide D c-[I(Thz)-tBuGly-FPIP] all-L





























Cyclic Biophysical data [137]
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Table 1. Cont.
Entry CPP Name Sequence α-CarbonConfiguration Source Design Approach Structural Features
Development
Stage Ref.
26 Cyclic sC18 c[GLRKRLRKFRNK]c-IKEK * all-L




positions 1 + 4, 1 + 8
and 1 + 12 of the linear
peptide








Cyclic Cell assays [49]
27 RRRRΦF *
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23 cFΦR4 c[FΦRRRRQ]c all-L 
Designed to contain Φ (L-2-
naphthylalanine) 
Varying design parameters used:  
sequence lengths; 
stereochemistry; or combination 
of the two 
Cyclic In vivo data [60,133] 
24 Danamide D c-[I(Thz)-tBuGly-FPIP] all-L Design based on cyclic 
heptapeptide sanguinamide A 
Rigid scaffold obtained through 
formation of a heterocycle; 
rigidity reinforced through 
bulky hydrophobic tertbutyl 
glycine side chains 




all-L, all-D or 
combination of  
L- and D-  
Inspired by cyclic natural 
products Guangomide A and 
baceridin 
Stereochemistry and N-
methylation us d to obtain 






26 Cyclic sC18 c[GLRKRLRKFRNK]c-IKEK * all-L 
Inspired by the CAP-18 
antimicrobial peptide; 
cyclization obtained by 
connecting residues at 
positions 1 + 4, 1 + 8 and 1 + 12 
of the linear peptide 
Gly and Lys residues replaced 
by propargylglycine and ε-
azidolysine to allow cyclization 
through triazole bridge 
formation by click chemistry 
Cyclic Cell assays [49] 




cyclization through cysteine 
side chains and 3,5-
bis(mercaptomethyl) benzoic 
acid (BMB) 
Designed to be conformationally 
constrained with the goal to 
induce the uptake of generally 
impermeable peptidyl drugs  
Cyclic Cell assays [134,138] 





Designed to have i + 4 staples 
(between X pairs; X is S-
pentenylalanine) or i + 7 
staples (between Z and X; Z is 
R-octenyl alanine 
Hydrophobic staple introduced 
for α-helical stabilization 
Stapled Cell assays [146] 
29 4-R 
4-W 
FITC-β-A (iso-DRRX)WRRW  
FITC-β-A (iso-DWWX)RWWR  
L- or D-
stereoisomers of 
Asp used  
Peptide bond formation 
between the side chain of the 
terminal Asp and the -NH2 of 
Dap (X is Dap) to obtain a 
crosslink  
Introduction of crosslinks (at 
similar distance to that 
introduced through stapling) to 
stabilize helical conformations 







Obtained by the self-assembly 
of coiled-coil peptides 
decorated with cationic 
segments (Sp = spermine) and 
PEG placed at opposite 
termini 
Supramolecular structures form 
due to the interaction of the 
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Dap) to obtain a
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Introduction of
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Table 1. Cont.
Entry CPP Name Sequence α-CarbonConfiguration Source Design Approach Structural Features
Development
Stage Ref.
31 K10(QW)6 KKKKKKKKKKQWQWQWQWQWQW all-L
The design was based
on combining W and K















(based on β-sheets) Cell assays [36,159]






Design based on four
main structural and
functional parameters:
palmitic acid (C16) tail
to drive self-assembly















motif to induce triple





Triple helix Cell assays [14]








Spherical aggregates Cell assays [160]
Peptido mimetics





Designed to mimic Tat






Flexible Biophysical data [81,88,97,98]
36 Peptoids(CPPos) Peptidomimetic molecules Not applicable




localization Flexible Cell assays [89,90]
37 CPDs Cell-penetrating disulfides Not applicable







bridges Cell assays [13,93–96]
* Several related sequences reported; only a representative example shown in the table.
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